XBIO logo

Xenetic Biosciences (XBIO) Retained Earnings

Annual Retained Earnings

-$193.23 M
-$4.13 M-2.19%

01 December 2023

XBIO Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Retained Earnings

-$196.14 M
-$436.60 K-0.22%

01 September 2024

XBIO Quarterly Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

XBIO Retained Earnings Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-2.2%-2.1%
3 y3 years-9.2%-8.5%
5 y5 years-26.1%-19.0%

XBIO Retained Earnings High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-9.2%at low-8.5%at low
5 y5 years-26.1%at low-19.0%at low
alltimeall time<-9999.0%at low<-9999.0%at low

Xenetic Biosciences Retained Earnings History

DateAnnualQuarterly
Sept 2024
-
-$196.14 M(+0.2%)
June 2024
-
-$195.70 M(+0.7%)
Mar 2024
-
-$194.43 M(+0.6%)
Dec 2023
-$193.23 M(+2.2%)
-$193.23 M(+0.6%)
Sept 2023
-
-$192.06 M(+0.6%)
June 2023
-
-$191.01 M(+0.6%)
Mar 2023
-
-$189.96 M(+0.5%)
Dec 2022
-$189.10 M(+3.6%)
-$189.10 M(+0.8%)
Sept 2022
-
-$187.62 M(+0.4%)
June 2022
-
-$186.81 M(+1.5%)
Mar 2022
-
-$184.14 M(+0.9%)
Dec 2021
-$182.55 M(+3.2%)
-$182.55 M(+1.0%)
Sept 2021
-
-$180.71 M(+0.8%)
June 2021
-
-$179.35 M(+0.6%)
Mar 2021
-
-$178.25 M(+0.8%)
Dec 2020
-$176.90 M(+6.6%)
-$176.90 M(+0.7%)
Sept 2020
-
-$175.70 M(+4.5%)
June 2020
-
-$168.14 M(+0.6%)
Mar 2020
-
-$167.19 M(+0.7%)
Dec 2019
-$166.01 M(+8.3%)
-$166.01 M(+0.7%)
Sept 2019
-
-$164.84 M(+5.7%)
June 2019
-
-$155.94 M(+0.9%)
Mar 2019
-
-$154.56 M(+0.9%)
Dec 2018
-$153.23 M(+5.0%)
-$153.23 M(+1.1%)
Sept 2018
-
-$151.59 M(+1.2%)
June 2018
-
-$149.78 M(+1.4%)
Mar 2018
-
-$147.76 M(+1.2%)
Dec 2017
-$145.93 M
-$145.93 M(-3.0%)
DateAnnualQuarterly
Sept 2017
-
-$150.38 M(+1.5%)
June 2017
-
-$148.12 M(+2.0%)
Mar 2017
-
-$145.20 M(+2.0%)
Dec 2016
-$142.34 M(+61.5%)
-$142.34 M(+0.3%)
Sept 2016
-
-$141.95 M(+1.8%)
June 2016
-
-$139.47 M(+52.1%)
Mar 2016
-
-$91.70 M(+4.1%)
Dec 2015
-$88.13 M(+16.5%)
-$88.13 M(+4.3%)
Sept 2015
-
-$84.50 M(+6.7%)
June 2015
-
-$79.18 M(+1.4%)
Mar 2015
-
-$78.06 M(+3.2%)
Dec 2014
-$75.62 M(+29.7%)
-$75.62 M(+6.0%)
Sept 2014
-
-$71.32 M(+4.7%)
June 2014
-
-$68.14 M(+4.2%)
Mar 2014
-
-$65.38 M(>+9900.0%)
Dec 2013
-$58.31 M(>+9900.0%)
-
Nov 2013
-
-$399.50 K(+26.0%)
Aug 2013
-
-$317.10 K(+31.6%)
Aug 2013
-$317.10 K(-99.4%)
-
May 2013
-
-$241.00 K(+6.0%)
Feb 2013
-
-$227.30 K(+49.1%)
Dec 2012
-$49.73 M(>+9900.0%)
-
Nov 2012
-
-$152.40 K(-33.1%)
Aug 2012
-
-$227.90 K(+141.2%)
Aug 2012
-$227.90 K(+2679.3%)
-
May 2012
-
-$94.50 K(+69.7%)
Feb 2012
-
-$55.70 K
Aug 2011
-$8200.00
-

FAQ

  • What is Xenetic Biosciences annual retained earnings?
  • What is the all time high annual retained earnings for Xenetic Biosciences?
  • What is Xenetic Biosciences annual retained earnings year-on-year change?
  • What is Xenetic Biosciences quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Xenetic Biosciences?
  • What is Xenetic Biosciences quarterly retained earnings year-on-year change?

What is Xenetic Biosciences annual retained earnings?

The current annual retained earnings of XBIO is -$193.23 M

What is the all time high annual retained earnings for Xenetic Biosciences?

Xenetic Biosciences all-time high annual retained earnings is -$8200.00

What is Xenetic Biosciences annual retained earnings year-on-year change?

Over the past year, XBIO annual retained earnings has changed by -$4.13 M (-2.19%)

What is Xenetic Biosciences quarterly retained earnings?

The current quarterly retained earnings of XBIO is -$196.14 M

What is the all time high quarterly retained earnings for Xenetic Biosciences?

Xenetic Biosciences all-time high quarterly retained earnings is -$55.70 K

What is Xenetic Biosciences quarterly retained earnings year-on-year change?

Over the past year, XBIO quarterly retained earnings has changed by -$4.08 M (-2.12%)